Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256527 · ClinicalTrials.gov registry record
REWARDS Premier Taxus-Liberte vs Xience V
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 917
- Enrollment target
NCT02256527: Completed study, sponsored by Medstar Health Research Institute.
NCT02256527 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 917 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02256527 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 917 participants
- Enrollment target
Study Summary
Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received either the Taxus Liberte or XIENCE V drug eluting stent.
Primary Outcome
composite of all-cause death, Q-wave myocardial infarction, and target vessel revascularization
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 917 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-10 |
What the finished NCT02256527 record still lists
NCT02256527 is an observational study that tracks outcomes without assigning an intervention. The registered 917 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT02256527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02256527 about?
NCT02256527 is a clinical study titled "REWARDS Premier Taxus-Liberte vs Xience V". Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received ...
What is the current status of trial NCT02256527?
This trial is currently completed. The enrollment target is 917 participants. The study started on 2014-09. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02256527?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT02256527?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05739955 · 918 participants · NA
Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia